Swedish Pharmaceuticals & Biotech Most Popular Stocks

Swedish Orphan Biovitrum

Market Cap: SEK 151.5b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Camurus

Market Cap: SEK 35.8b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

BioArctic

Market Cap: SEK 28.0b

Develops biological drugs for patients with central nervous system disorders in Sweden.

AddLife

Market Cap: SEK 20.0b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

Bonesupport Holding

Market Cap: SEK 14.7b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Vitrolife

Market Cap: SEK 12.2b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioGaia

Market Cap: SEK 11.5b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Swedencare

Market Cap: SEK 3.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Hansa Biopharma

Market Cap: SEK 3.4b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Vicore Pharma Holding

Market Cap: SEK 3.1b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Egetis Therapeutics

Market Cap: SEK 3.0b

A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.

Saniona

Market Cap: SEK 1.9b

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.

Flerie

Market Cap: SEK 1.8b

A venture capital firm specializing in early-stage investments.

BioInvent International

Market Cap: SEK 1.5b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.

Cereno Scientific

Market Cap: SEK 1.5b

A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Curasight

Market Cap: DKK 768.8m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

Medivir

Market Cap: SEK 1.1b

A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.1b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BICO Group

Market Cap: SEK 1.1b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Infant Bacterial Therapeutics

Market Cap: SEK 916.1m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

AlzeCure Pharma

Market Cap: SEK 868.8m

Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

Xspray Pharma

Market Cap: SEK 787.1m

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Hamlet BioPharma

Market Cap: SEK 746.3m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Dicot Pharma

Market Cap: SEK 709.7m

Engages in the development of pharmaceutical products in Sweden.

Oncopeptides

Market Cap: SEK 632.5m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Cinclus Pharma Holding

Market Cap: SEK 556.6m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Orexo

Market Cap: SEK 513.3m

A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.

FluoGuide

Market Cap: SEK 506.8m

A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.

Enzymatica

Market Cap: SEK 461.2m

A life science company, develops and sells medical devices for infectious diseases.

Corline Biomedical

Market Cap: SEK 458.6m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.

Moberg Pharma

Market Cap: SEK 449.3m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Cantargia

Market Cap: SEK 447.5m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Mendus

Market Cap: SEK 437.8m

A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.

Intervacc

Market Cap: SEK 430.1m

Develops novel veterinary vaccines for animals in Sweden.